Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-001801

10% owner bought 50,000 shares at an average $4.72 ($235,824)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cambrian BioPharma Inc 10% owner 2022-01-25 Purchase +20,100 $4.86 $97,686 5,083,386 D: show line 1 in the form
Cambrian BioPharma Inc 10% owner 2022-01-26 Purchase +29,900 $4.62 $138,138 5,113,286 D: show line 2 in the form
Open-market purchases · 50,000 sh · avg $4.72 · $235,824
Loading xslF345X03/doc1.xml…